At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
MoreNovadevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Immediate and Short Term Efficacy of Low Intensity Shock Wave Therapy in the Management of Erectile Dysfunction Due to Mild - Moderate Cavernous Arterial Insufficiency
In Brief
A clinical study evaluating MoreNova for Erectile Dysfunction. Completed, enrolled 6 participants across 1 site.
Detailed Summary
Researchers are evaluating the efficacy of low intensity shockwave therapy (LISWT) via MoreNova in the treatment of erectile dysfunction (ED).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsErectile Dysfunction
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartDec 2019
Primary CompletionJul 2023
TodayJul 2026
First PostedOct 23, 2019
Enrollment StartDec 1, 2019
Primary CompletionJul 1, 2023
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 6.7 years ago
Interventions
MoreNovadevice
Shockwave therapy delivered to the genital area with low dose shocks